Quality needs and evaluation of antimalarial medicines

This book is a compilation of visual and laboratory-based activities that are supposed to be satisfied before every antimalarial medicine (artemisinin-based combination therapy) and non-artemisinin based combination therapy) is declared fit for human consumption and these methods are suitable for both developed and developing countries. However, the book discusses the methods with emphasis on developing countries, which are in dire need of relatively cheap but effective methods of pharmaceutical analysis due to increased circulation of poor quality medicines, which has been influenced by high disease burden (hence high demand for medicines which are expensive and more money fetching for counterfeiters) and poor regulatory frameworks. The book goes further to discuss the implications of using poor quality medicines (fake, substandard and degraded) on the human health and healthcare system as result of lack of adherence to quality evaluation criteria recommended worldwide and discussed in the text.

Autorentext

Ibrahim Chikowe attended Mzuzu University (Malawi) for a Bachelor of Science (Education) degree.He has also attended University of Ghana for his Master of Philosophy Degree in Chemistry under the DFID/Wellcome Trust fellowship. Currently, he is a Lecturer at the University of Malawi, College of Medicine.